相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude
Ruth Dobson et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome
M. Khalil et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Intense Inflammation and Nerve Damage in Early Multiple Sclerosis Subsides at Older Age: A Reflection by Cerebrospinal Fluid Biomarkers
Mohsen Khademi et al.
PLOS ONE (2013)
CSF abnormalities can be predicted by VEP and MRI pathology in the examination of optic neuritis
Henrik Horwitz et al.
JOURNAL OF NEUROLOGY (2012)
Will the real multiple sclerosis please stand up?
Peter K. Stys et al.
NATURE REVIEWS NEUROSCIENCE (2012)
Role of Chitin and Chitinase/Chitinase-Like Proteins in Inflammation, Tissue Remodeling, and Injury
Chun Geun Lee et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 73 (2011)
Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosis
Jorge Correale et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis
Lars Bornsen et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course
Mohsen Khademi et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Inflammatory Cortical Demyelination in Early Multiple Sclerosis
Claudia F. Lucchinetti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis
Manuel Comabella et al.
BRAIN (2010)
In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases
Dafna Bonneh-Barkay et al.
JOURNAL OF NEUROINFLAMMATION (2010)
Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid
J. Mellergard et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)
Johannes Brettschneider et al.
PLOS ONE (2010)
The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers
M. Khademi et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis
C. E. Teunissen et al.
NEUROLOGY (2009)
Increased osteopontin levels in the cerebrospinal fluid of patients with multiple sclerosis
Manjit Braitch et al.
ARCHIVES OF NEUROLOGY (2008)
Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis
Soheli A. Chowdhury et al.
ARCHIVES OF NEUROLOGY (2008)
Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis
Lisa K. Peterson et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells
Eun Mi Hur et al.
NATURE IMMUNOLOGY (2007)
Matrix metalloproteinase-9 and autoimmune diseases
Maya Ram et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2006)
Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis
J Brettschneider et al.
MULTIPLE SCLEROSIS JOURNAL (2006)
Multiple sclerosis cerebrospinal fluid biomarkers
Gavin Giovannoni
DISEASE MARKERS (2006)
Acute axonal damage predicts clinical outcome in patients with multiple sclerosis
ET Lim et al.
MULTIPLE SCLEROSIS JOURNAL (2005)
Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis -: A consensus statement
MS Freedman et al.
ARCHIVES OF NEUROLOGY (2005)
Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis
B Serafini et al.
BRAIN PATHOLOGY (2004)
Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patients
MHJ Vogt et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS
C Malmeström et al.
NEUROLOGY (2003)
Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system
F Sellebjerg et al.
BRAIN RESEARCH BULLETIN (2003)
Multiple sclerosis:: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system
TL Sorensen et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Heightened intrathecal release of axonal cytoskeletal proteins in multiple sclerosis is associated with progressive disease and clinical disability
YK Semra et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease
D Chabas et al.
SCIENCE (2001)
分享论文
